Vilma Pacheco-Barcía

664 total citations
29 papers, 438 citations indexed

About

Vilma Pacheco-Barcía is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vilma Pacheco-Barcía has authored 29 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 5 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vilma Pacheco-Barcía's work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer survivorship and care (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Vilma Pacheco-Barcía is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Cancer survivorship and care (4 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Vilma Pacheco-Barcía collaborates with scholars based in Spain, Palestinian Territory and Canada. Vilma Pacheco-Barcía's co-authors include Rámón Colomer, Jacobo Rogado, O. Donnay, Nuria Romero-Laorden, Pedro Gullón, Javier Aspa, J.M. Sánchez-Torres, Ana M. Ramos‐Leví, Magdalena Adrados and Arántzazu Alfranca and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Vilma Pacheco-Barcía

27 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vilma Pacheco-Barcía Spain 9 345 118 69 58 53 29 438
Hyerim Ha South Korea 10 222 0.6× 74 0.6× 129 1.9× 43 0.7× 43 0.8× 25 376
Fadi El Karak Lebanon 13 225 0.7× 155 1.3× 78 1.1× 34 0.6× 25 0.5× 51 462
Hiren Mandaliya Australia 8 248 0.7× 111 0.9× 40 0.6× 43 0.7× 49 0.9× 21 371
Ahmet Sezer Türkiye 11 235 0.7× 168 1.4× 77 1.1× 34 0.6× 33 0.6× 48 402
Marium Husain United States 8 224 0.6× 83 0.7× 35 0.5× 40 0.7× 28 0.5× 34 300
Swee Peng Yap Singapore 11 187 0.5× 78 0.7× 96 1.4× 38 0.7× 38 0.7× 23 372
Caroleen Quach United States 8 188 0.5× 70 0.6× 28 0.4× 59 1.0× 82 1.5× 13 342
Luciano Paladini Brazil 8 213 0.6× 96 0.8× 97 1.4× 29 0.5× 50 0.9× 20 526
Aurélia Meurisse France 12 250 0.7× 157 1.3× 121 1.8× 36 0.6× 78 1.5× 48 429
Amanda V. Hayman United States 11 245 0.7× 63 0.5× 192 2.8× 100 1.7× 29 0.5× 26 493

Countries citing papers authored by Vilma Pacheco-Barcía

Since Specialization
Citations

This map shows the geographic impact of Vilma Pacheco-Barcía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilma Pacheco-Barcía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilma Pacheco-Barcía more than expected).

Fields of papers citing papers by Vilma Pacheco-Barcía

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vilma Pacheco-Barcía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilma Pacheco-Barcía. The network helps show where Vilma Pacheco-Barcía may publish in the future.

Co-authorship network of co-authors of Vilma Pacheco-Barcía

This figure shows the co-authorship network connecting the top 25 collaborators of Vilma Pacheco-Barcía. A scholar is included among the top collaborators of Vilma Pacheco-Barcía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilma Pacheco-Barcía. Vilma Pacheco-Barcía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabezón‐Gutiérrez, Luis, et al.. (2025). Metabolic mechanisms of immunotherapy resistance. Exploration of Targeted Anti-tumor Therapy. 6. 1002297–1002297. 6 indexed citations
2.
Pacheco-Barcía, Vilma, Alberto Carmona‐Bayonas, Javier Gállego, et al.. (2024). Nutritional impact and prognostic role of systemic inflammatory response index (SIRI) in advanced pancreatic cancer: PANTHEIA-Spanish Society of Medical Oncology (SEOM) study results.. Journal of Clinical Oncology. 42(3_suppl). 623–623. 1 indexed citations
3.
Pacheco-Barcía, Vilma, et al.. (2024). Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC). Urologic Oncology Seminars and Original Investigations. 42(10). 331.e13–331.e24. 1 indexed citations
4.
Pacheco-Barcía, Vilma, Alberto Carmona‐Bayonas, Javier Gállego, et al.. (2024). Systemic Inflammation Response Index and weight loss as prognostic factors in metastatic pancreatic cancer: A concept study from the PANTHEIA-SEOM trial. World Journal of Gastrointestinal Oncology. 16(2). 386–397. 4 indexed citations
5.
Ramchandani, Avinash, Raquel Hernández, Estrella Ferreira, et al.. (2023). Psychological factors and prognostic communication preferences in advanced cancer: multicentre study. BMJ Supportive & Palliative Care. 13(e3). e1342–e1350. 4 indexed citations
6.
Cabezón‐Gutiérrez, Luis, et al.. (2023). Prognostic Factors of Nintedanib-docetaxel in Patients with Previously Treated Non-small-cell Lung Cancer. 5(2). 74–82. 1 indexed citations
7.
Pacheco-Barcía, Vilma, et al.. (2023). Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma. SHILAP Revista de lepidopterología. 4(2). 307–315.
8.
Rogado, Jacobo, Fernando Campo del Pozo, Kevin Troulé, et al.. (2022). Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC. Cancers. 14(12). 2898–2898. 8 indexed citations
9.
Tarazona, Noelia, Vilma Pacheco-Barcía, Berta Obispo, et al.. (2022). Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section. Clinical & Translational Oncology. 25(3). 796–802. 2 indexed citations
10.
Jiménez‐Fonseca, Paula, Raquel Hernández, Mireia Gil-Raga, et al.. (2022). Psychological distress and resilience in patients with advanced cancer during the Covid-19 pandemic: the mediating role of spirituality. BMC Palliative Care. 21(1). 146–146. 18 indexed citations
11.
Pacheco-Barcía, Vilma, David Gómez, Berta Obispo, et al.. (2022). Role of sex on psychological distress, quality of life, and coping of patients with advanced colorectal and non-colorectal cancer. World Journal of Gastrointestinal Oncology. 14(10). 2025–2037. 4 indexed citations
12.
Ciria‐Suarez, Laura, Caterina Calderón, Ana Fernández Montés, et al.. (2021). Correction to: Optimism and social support as contributing factors to spirituality in Cancer patients. Supportive Care in Cancer. 29(6). 3375–3376. 1 indexed citations
13.
Carmona‐Bayonas, Alberto, Caterina Calderón, Raquel Hernández, et al.. (2021). Prediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy. npj Breast Cancer. 7(1). 92–92. 13 indexed citations
14.
Pacheco-Barcía, Vilma, Berta Obispo, David Páez, et al.. (2021). 1847P Professional standing of young medical oncologists in Spain during COVID-19 pandemic: A nationwide survey by the Spanish Society of Medical Oncology (SEOM) +MIR Section. Annals of Oncology. 32. S1245–S1246. 1 indexed citations
15.
Pacheco-Barcía, Vilma, T. France, Jamil Asselah, et al.. (2019). A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology. 20(2). 254–264. 57 indexed citations
16.
Rogado, Jacobo, J.M. Sánchez-Torres, Nuria Romero-Laorden, et al.. (2019). Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. European Journal of Cancer. 109. 21–27. 192 indexed citations
17.
Pacheco-Barcía, Vilma, Rebeca Mondéjar, Olga Martínez‐Sáez, et al.. (2019). Safety and Oncological Outcomes of Bevacizumab Therapy in Patients With Advanced Colorectal Cancer and Self-expandable Metal Stents. Clinical Colorectal Cancer. 18(3). e287–e293. 14 indexed citations
18.
Rogado, Jacobo, Nuria Romero-Laorden, J.M. Sanchez Torres, et al.. (2019). Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs).. Journal of Clinical Oncology. 37(15_suppl). e14064–e14064. 1 indexed citations
19.
Pacheco-Barcía, Vilma, T. France, George Zogopoulos, et al.. (2018). Gemcitabine plus nab-paclitaxel versus modified FOLFIRINOX as first line chemotherapy in metastatic pancreatic cancer: A comparison of toxicity and survival. Annals of Oncology. 29. v46–v46. 7 indexed citations
20.
Quintas, Sonia, Jacobo Rogado, Pedro Gullón, et al.. (2018). Predictors of unknown cancer in patients with ischemic stroke. Journal of Neuro-Oncology. 137(3). 551–557. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026